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Abstract
Background: The utility of blood reproductive endocrine biomarkers for assessing or estimating
semen quality was explored.
Methods: A cross-sectional study of 47 DDT exposed malaria vector control workers was
performed. Tests included blood basal and post gonadotrophin releasing hormone (GnRH),
lutenizing hormone (LH), follicle stimulating hormone (FSH), testosterone, sex hormone binding
globulin (SHBG), estradiol (E2) and inhibin; a questionnaire (demographics and general medical
history); a physical examination and semen analysis. Semen parameters were determined using
either/or or both WHO or the strict Tygerberg criteria. Relationships between semen parameters
and endocrine measures were adjusted for age, duration of abstinence before sampling, presence
of physical abnormalities and fever in the last two months. All relationships between specific
endocrine hormones were adjusted for age and basal SHBG.
Results: Multiple logistic regression showed a consistent positive relationship (prevalence odds
ratio (POR) = 8.2, CI:1.4–49.2) between low basal inhibin (<100 pg/ml) and low semen count (< 40
million) and density (< 20 million/ml); consistent positive, but weaker relationships (1> POR < 2)
between abnormally low semen count as well as density and baseline and post GnRH FSH; and
positive relationships (POR = 37, CI:2–655) between the prevalence of high basal estradiol (> 50
pg/ml) and abnormal morphology (proportion < 5%) and low motility (proportion <50%). Most of
the expected physiological relationships between specific endocrines were significant.
Conclusion: The study has demonstrated that low basal inhibin, elevated basal FSH and high basal
E2 can serve as markers of impaired semen quality.
Background
Semen quality parameters are routine clinical measures
used to assess testicular function and basal blood repro-
ductive endocrine levels are used to assess the integrity of
the hypothalamus-pituitary-testicular axis. The GnRH
stimulation test has also been used to indicate disruption
in the normal hypothalamic-pituitary-testicular axis
(HPT) [1,2] in men with significant gonadal dysfunction
due to testicular disorders such as cryptorchidism, varic-
ocele, testicular torsion and vasectomy [2].
Published: 10 August 2006
Journal of Occupational Medicine and Toxicology 2006, 1:21 doi:10.1186/1745-6673-1-21
Received: 04 July 2005
Accepted: 10 August 2006
This article is available from: http://www.occup-med.com/content/1/1/21
© 2006 Dalvie and Myers; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Occupational Medicine and Toxicology 2006, 1:21 http://www.occup-med.com/content/1/1/21
Page 2 of 7
(page number not for citation purposes)
A number of epidemiological studies have investigated
the relationships between semen quality and endocrine
measures mostly in men diagnosed with infertility [1,3-
12]. Basal inhibin has been shown to be predictive of
semen quality having positive relationships with most
semen parameters, especially semen count [3-5,7,9].
There is also evidence that basal FSH has a negative rela-
tionship with semen quality [3,8,10]. Gerhard et al. [12]
did not find significant relationships between post GnRH
challenge hormone levels and semen parameters. Few epi-
demiological studies have investigated relationships
between individual blood reproductive endocrine levels
[1,3,5,11]. A negative relationship between basal inhibin
and basal FSH was the only physiological relationship
consistently found. Besser [1] did not find relationships
between basal and post GnRH challenge blood hormone
levels.
No studies could be found in the literature that have com-
prehensively examined to what extent blood endocrines
predict semen parameters or examined relationships
between individual blood endocrines in humans.
Although most previous studies controlled for factors
such as abstinence and age through the selection of study
subjects for relationships between semen parameters and
blood endocrines, a limitation was that other covariates
was not controlled for. This study examines the relation-
ship between a number of semen parameters and endo-
crine measures as well as relationships between individual
blood endocrines controlling for relevant covariates, in
malaria control workers investigated for the reproductive
effects of DDT where no DDT effect was found [13,14].
Methods
Subjects, questonnaire and physical examination
The details of the study methods are described elsewhere
[3-15]. Briefly, a cross-sectional study of Pedi-speaking
workers (n = 47) from three camps in the vicinity of the
Department of Health Malaria Control Centre (MCC) in
Tzaneen, Limpopo, was performed.
A questionnaire [13] including amongst others, sections
on demographics and general medical history was admin-
istered by trained interviewers. A doctor performed an
abbreviated physical examination of the reproductive sys-
tem recording height, weight, secondary sexual character-
istics (Tanner stage) and genital anatomical
abnormalities. The presence of infection, previous injury,
hernias or tumours were assessed.
Endocrine measures
Baseline and post-GnRH (100 µg) challenge test levels of
pituitary and gonadal hormones FSH, LH, testosterone,
estradiol (E2), SHBG and Inhibin-B were measured. The
Department of Chemical Pathology at the University of
Cape Town measured LH with the MAIAclone IRMA kit
[16,17], FSH and total testosterone with ACS-180 compet-
itive chemiluminescent automated systems [18], estradiol
with an in-house radioimmunoassay [19] and SHBG with
the IRMA kit from Orion Diagnostica [20]. Laboratory
inter- and intra-assay variation was less than 6.8% and
13% respectively [15]. Inhibin B was measured by the
Centre for Reproductive Biology, Medical Research Coun-
cil, Edinburgh, United Kingdom using an internally vali-
dated two site enzyme-linked immunoassay [21-23].
Baseline hormones were compared to manufacturers ref-
erence values, while for SHBG, the laboratory's internal
reference range (12.7–55 nmol/L) was used because it dif-
fered from the manufacturers' range (11–71 nmol/L).
Semen quality
Workers were requested to produce semen samples by
masturbation or coitus interruptus (which was more cul-
turally compatible with the beliefs and practices of partic-
ipants) after 2 days of abstinence, one hour before
collection time, and to keep them at body temperature.
Collected samples were then immediately transported (at
room temperature) to the MCC laboratory and incubated
at room temperature. An experienced reproductive biolo-
gist performed analysis including semen volume (to the
nearest 0.1 ml in a graded tube); sperm count (millions)
diluted 1:20 with formalin buffer in an improved Neu-
bauer hemacytometer and using the phase-contrast tech-
nique at a magnification of 40; sperm density (millions/
ml); quantitative sperm motility (% motile relative to
immobile sperm, estimated to the nearest 5%) at a mag-
nification of 20 using an undiluted semen sample of ≤ 10
µl ; as well as liquefaction, consistency, pH, and agglutina-
tion, following World Health Organisation protocols
[24]. Air-dried slides were air shipped to the Department
of Obstetrics and Gynaecology at the University of Cape
Town for morphology determination (% normal) using
the strict Tygerberg criteria [25]. Slides were fixed in 80%
alcohol and stained using a modification of Papanicolou's
stain. A phase contrast light microscope was used for
semen analysis.
Statistical analysis
Semen parameters and endocrine measures were analysed
as both continuous variables and dichotomous variables.
Dichotomous cut-offs for semen parameters were based
on WHO (density < 20 million/ml, count < 40 million
and motility < 50%) [24] and/or Tygerberg (morphology
< 2%) criteria [25], while basal endocrines were dichot-
omised at upper and lower limits of the reference ranges
and post-GnRH challenge hormones at zero, upper and
lower quartiles. Blood hormone responses to GnRH, were
analysed as the absolute change at different time points
from the mean of the two pre-challenge baseline meas-Journal of Occupational Medicine and Toxicology 2006, 1:21 http://www.occup-med.com/content/1/1/21
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ures. The peak change across all timepoints and the
summed change over all timepoints were calculated. Uni-
variate, bivariate and multivariate analyses, using multi-
ple linear and multiple logistic regression analysis, were
performed for relevant variables. The relationship
between semen parameters and endocrine measures on
the one hand, and between basal and post GnRH endo-
crine levels on the other were explored. In multivariate
modeling, semen parameters were treated as outcomes for
relationships with endocrine levels adjusting for age,
abstinence from sex, the presence of structural or patho-
logical abnormalities and fever in the last 2 months, while
basal hormone levels were outcomes for relationships
with post GnRH challenge levels of the same hormone
adjusting for age and basal SHBG. Covariates were
selected a priori based on biological plausibility, or were
based on bivariate analysis yielding associations where
the p-value was < 0.1. DDT was not a significant covariate.
Analysis was conducted using Stata 8 [26]. Multiple linear
regression models were evaluated for normality of residu-
als, homogeneity of variances, and collinearity. Multiple
linear and logistic regression models were tested for the
form of the linear predictor and for the adequacy of the
link function. Where there was evidence of skewness in
the distribution of the residuals for multiple linear regres-
sion, this was alleviated by logarithmic transformations,
but because the transformed models did not change the
nature of associations, the untransformed models are pre-
sented. For multiple linear regression analyis, collinearity
was identified if r > 0.9 or a variance inflation factor > 10,
and the effect of outliers/influential points, identified by
DFBETAs > 1, Cook's D > 0.5 or Student residuals > 2.5
while outliers and influential points for multiple logistic
regression analysis were identified if standardized residu-
als were > 2 or < -2 or if leverage patterns were far from the
average covariate pattern. Outliers and influential points
did not have an effect on the nature of the multivariate
associations and the results of relationships including all
points are therefore presented. The adjusted R2 indicates
the proportion of the total variance explained by a multi-
variate model after adjusting for the number of variables
in the model. The term "R2" is, however, used to avoid
confusion with term "adjusted effect" and "adjusted  ".
Ethical approval
The study was conducted in accordance with national and
institutional guidelines for the protection of human sub-
jetcs. The study protocol was approved by the University
of Cape Town's Ethics Committee and by the University of
Michigan Internal Review Board. Written informed con-




Descriptive results are described in detail elsewhere
[13,14]. Briefly the participants had a high mean age of
43.3 (SD = 9.0 years). The prevalence of abnormal semen
(any abnormality) amongst the participants was high (>
45%). Median baseline LH, FSH, SHBG and testosterone
of workers were within normal (laboratory reference)
ranges, while median baseline E2 was above the upper
limit (50 pg/ml) of normal. Sixty five percent of partici-
pants' baseline E2s, 2% LH and FSH, 14% testosterone,
18% SHBGs and no inhibin were above the upper limit of
normal, while 23% baseline LH and FSH, 2% E2 and
SHBG and 4% testosterone and 45% inhibin were below
the lower limit of normal. As indicated in Table 1, post
GnRH responses of LH and FSH were well above baseline
values, while post GnRH testosterone, inhibin and estra-
diol responses were much less and sometimes negative.
Table 1 compares the baseline and post peak GnRH chal-
lenge blood hormone levels between participants with
normal and abnormal semen parameters. Sum post
GnRH challenge hormone results were similar to the peak
post GnRH challenge results presented, and are not
shown. Age and abstinence was high. Median baseline E2
(normal range: 10–50 pg/ml) was consistently higher
than the high end of the normal range in all paired
groups, while baseline inhibin (normal range 100–400
pg/ml) were lower than the normal range for participants
with abnormal semen counts and densities. Baseline LH
(normal range: 1.5–9.2 miu/ml), FSH (normal range:
1.4–18.1 miu/ml) testosterone (8.4–28.8) and SHBG
(normal range: 12.7–55 nmol/L) were all in the normal
range for all groups.
Multivariate relationships between semen parameters and 
endocrine measures
Table 2 summarises the significant multiple linear and
logistic regression analysis relationships between semen
parameters treated as outcomes and basal and post GnRH
challenge blood endocrine levels adjusting for age, absti-
nence period, the presence of one or more physical abnor-
malities and fever in the last 2 months. Most of the
significant relationships were with semen count and den-
sity.
There was a consistent positive relationship between low
basal inhibin and low semen count and density (positive
relationship between abnormally low semen count and
abnormally low basal inhibin, negative relationship
between abnormally low semen count and baseline




















































































































































Table 1: Comparison of blood hormone levels of participants with normal and abnormal sperm
Variable Median (range)
Semen count Semen density Semen Motility Normal semen morphology
≥ 20 × 106 (n = 26) < 20 × 106 (n = 17) ≥ 40 × 106/ml (n = 31) < 40 × 106/ml (n = 14) ≥ 50% (n = 29) < 50% (n = 14) ≥ 2% (n = 25) < 2% (n = 16)
Basal:
LH (mui/ml) 1.8 (0.7;4.7) 2.7 (1.3;11.7) 2.3 (0.7;4.7) 2.2 (1.3;11.7) 2.1 (0.7;4.6) 2.5 (1.4;6.2) 2.3 (0.7;4.6) 2.2 (0.7;6.2)
FSH(mui/ml) 2.7 (0.1;2.2) 3.9 (0.8;19.9) 2.5 (0.1;7.2) 3.9 (1.7 ;19.9) 2.7 (0.1;7.3) 3.6 (0.1;8.5) 2.7 (0.1;2.2) 2.7 (1.1;8.5)
TST (nmol/L) 18.4 (8.0;39.5) 17.0 (9.3;39.4) 20.2 (4.7;39.5) 15.8 (9.3;32.1) 16.4 (4.7;39.4) 20.6(13.7;39.5) 17 (4.7;32.5) 18.1(9.7;32.1)
E2 (pg/ml) 53.5 (2.0;208.5) 55.0 (13.5;115.5) 53.5 (2.0;208.5) 55.0 (15.0;115.5) 53.5 (2.0;122) 73 (36;208.5) 48.3 (2;208.5) 69.3 (50;159.5)
IHB (pg/ml) 121.1(33.4;231.3) 73.3(25.2;192.2) 122.0 (35.4; 244.7) 81.4 (25.2;164.1) 115.3 (35.4;244.7) 133.8 (50.1;202.8) 123.3 (35.4;244.7) 101.4 (37.9;173.1)
SHBG (nmol/L) 32.8 (15.5;95.0) 37.0 (12.0;76.5) 33.5 (15.5; 95.0) 35.5 (12.0;76.5) 33.0 (12.0;95.0) 37.8 (23.5;65.5) 34 (15.5;95.0) 34.3 (16.0;66.0)
Peak Post GnRH: (n = 21) (n = 16) (n = 25) (n = 13) (n = 22) (n = 23) (n = 13) (n = 13)
LH (mui/ml) 14.6 (4.8;35.1) 25.9 (7.5;83.3) 15.6 (4.8;67.0) 22.9 (7.3;83.3) 16.7 (4.8;67.0) 16.4 (4.8;83.3) 16.4 (5.5;40.3) 18.4 (5.5;40.3)
FSH (mui/ml) 3.0 (0.6;8.5) 5.4 (1.0;27.6) 3.2 (0.6;11.2) 5.6 (2.4;27.6) 3.2 (0.6;11.2) 3.2 (0.8;27.6) 4.9 (0.9;11.4) 4.9 (0.6;11.4)
TST (nmol/L) 3.35 (-5.25;21.6) 0.6 (-7.5;18.7) 3.3 (-7.5;21.6) 0.6 (-5.7;18.7) 2.9 (-7.5;21.6) 2.5 (-7.8;21.6) 1.6 (-0.6;16.8) 0.6 (-5.3;16.8)
E2 (pg/ml) 8.5 (-70.5;95.0) 13.0 (-45.5;49.0) 11.5 (-70.5;95) 3.5 (-45.5;49.0) 10.8(-70.5;95.0) 8.5 (-70.5;95.0) 8.5 (-45.5;49) 15.0 (-45.5;49)
IHB (pg/ml) 20.7 (-61.4;136.7) 7.7 (-54.8;188.7) 20.7(-61.4;188.7) 9.6 (-15; 67.4) 32.0 (-61.4;188.7) 20.7 (-61.4;188.7) 9.6 (-22.8;132.6) 9.6(-22.9;132.6)
Age (years) 48 (26;60) 44 (30;59) 49 (26;60) 41 (31;58) 46 (26;60) 48 (31;58) 49 (26;60) 45 (31;58)
Abstinence (days) 3.0 (0.2;8.5) 3.0 (1.4;14.3) 3.3 (5.0;10.4) 2.3 (0.2;14.3) 3.1 (2.2;8.5) 2.8 (1.3;14.3) 3.3 (0.2;14.3) 2.7 (1.3;8.2)Journal of Occupational Medicine and Toxicology 2006, 1:21 http://www.occup-med.com/content/1/1/21
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abnormally low baseline inhibin, positive relationship
between semen density and baseline inhibin). For exam-
ple, Table 3 shows that for the relationship between
abnormally low semen count and abnormally low basal
inhibin, the latter is the only significant covariate with a
high prevalence odds ratio = 8.2.
There were consistent positive, but weaker relationships
(1> prevalence odds ratios < 2) between abnormally low
semen count and density with baseline and post GnRH
FSH levels (positive relationships between abnormally
low semen count with baseline and post GnRH peak FSH,
positive relationship between abnormally low density
and baseline FSH).
Table 2 also shows that there were significant positive
relationships between the prevalence of abnormally high
basal estradiol with abnormally low morphology and
motility. Table 4 shows a strong relationship between
abnormally low morphology and abnormally high basal
E2 (prevalence odds ratio = 37, CI:2–655).
Multivariate relationships between endocrine hormones
Basal E2 and testosterone were not significantly related to
basal LH. Basal LH and basal FSH were positively associ-
ated. (Adjusted  = 0.42 (SD = 0.53), p < 0.0005, R2 =
0.62, n = 49). Basal testosterone had a strong positive
association (Adjusted  = 2.58 (SD = 0.65), p < 0.0005, R2
= 0.31, n = 49) with basal E2. Basal FSH had a significant
negative relationship to basal inhibin (Adjusted   = 0.03
(SD = 0.007), p < 0.0005, R2 = 0.27, n = 49)
The only significant relationships among basal and post
GnRH challenge hormone levels of the same hormone
when adjusted for age and baseline SHBG, were between
basal FSH and both the peak post GnRH FSH (  = 0.269
(SD = 0.107), p = 0.017, R2 = 0.11, n = 42) and the sum
post GnRH FSH (  = 0.086 (SD = 0.038), p = 0.029, R2 =
0.27), n = 26), and also between basal E2 and the sum
post GnRH E2 (  = -0.167 (SD = 0.077), p = 0.042, R2 =
0.11, n = 26).
Baseline SHBG was a significant positive predictor of
baseline testosterone (  = 0.26 (SD = 0.46, p < 0.0005, R2
= 0.39, n = 26), but a negative predictor of post GnRH
challenge peaks of testosterone (  = -0.12 (SD = 0.42), p
= 0.016, R2 = 0.16, n = 26) and E2 (  = -0.51 (SD = 0.18),
p = 0.006, R2 = 0.14, n = 26) when adjusting for age.
Age was not a significant covariate of endocrine hor-
mones, but was positively associated with baseline SHBG
(  = 0.86 (SD = 0.36), p = 0.021, R2 = 0.09, n = 49).
Discussion
This study did not find consistent relationships between











Table 2: Significant multivariate associations between semen outcomes and endocrine measures
Semen Parameter Endocrine Measure Beta (SE) P Odds Ratio (CI) R2
Abnormal semen count (< 20 × 106) Baseline inhibin 0.048 0.98 (0.96–0.99) 0.14
Baseline FSH 0.021 1.69 (1.05–2.8) 0.22
Post Peak GnRH LH 0.015 1.15 (1.03–1.3) 0.24
Post Peak GnRH FSH 0.033 1.4 (1.0–1.9) 0.18
Abnormally low baseline Inhibin (< 100 pg/ml) 0.032 8.2 (1.4–49.2) 0.18
Density Abnormally low baseline inhibin -69.5 (32.2) 0.039 0.05
Baseline testosterone -3.8 (1.83) 0.046 0.04
Baseline inhibin 0.8 (0.3) 0.01 0.25
Abnormal Density (< 40 × 106/ml) Baseline FSH 0.028 1.85 (1.1–3.2) 0.14
Abnormal morphology (< 2%) Abnormally high baseline E2 (> 50 pg/ml) 0.013 37.2 (2.1–655.2) 0.18
Abnormal motility (< 50%) Abnormally high baseline E2 0.046 39.5 (1.1–1450) 0.34
Morphology Abnormally high baseline E2 -1.27 (0.58) 0.036 0.21
* CI: 95% confidence interval
Covariates included in models: age, abstinence, presence of physical abnormality and fever in the last two monthsJournal of Occupational Medicine and Toxicology 2006, 1:21 http://www.occup-med.com/content/1/1/21
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parameters amongst the study participants, but rather
relationships between some semen parameters below
WHO and Tygerberg criteria and some blood endocrines
especially for values outside the reference range. Most of
the expected physiological relationships between basal
levels of hormones in the male hypothalamus-pituitary-
gonadal axis, as well as relationships between basal hor-
mones and SHBG were found in this study. With respect
to relationships between blood basal and post GnRH lev-
els of the same hormone, there were few significant rela-
tionships.
The positive relationship between semen count and basal
inhibin levels and the negative relationship between
semen count and basal FSH found in this study is consist-
ent with the literature [3-5,7-10], suggesting that these
hormones are markers of impaired spermatogenesis. This
study has shown that abnormally low basal inhibin (<
100 pg/ml) strongly predicts abnormally low semen
counts. No criteria could be set for FSH because blood
basal levels in this study sample were well within the
upper limit of normal (18.1 nmol/L). Jensen et al. [6]
found criteria of basal inhibin < 80 pg/ml and FSH > 10
miu/ml to be 100% predictive of semen counts < 20 per
millimeter. These criteria, however, seem more relevant
for a clinical setting because in this study only one partic-
ipant had such a low basal inhibin and high FSH, and he
had a semen count of zero. The results in this study also
suggest that abnormally high basal E2 (> 50 pg/ml) could
be a marker of abnormally low semen morphology (< 2%
normal) and motility (< 50%), possibly reflecting
increased LH and testosterone release in the hypothala-
mus-pituitatry-testis-axis. The lack of a relationship of
basal LH and testosterone with semen parameters and
other hormones could be due to the wide range and fluc-
tuations of these hormones [3].
The GnRH test was not found to add much information to
that provided by basal blood endocrine levels with respect
to relationships with semen parameters. Previously, Ger-
hard et al. [12] also did not find correlations between
semen parameters and post GnRH hormone levels. The
increased post GnRH blood LH and FSH (Table 2) levels
found amongst those with abnormally low semen count
(Table 2) in this study could reflect decreased negative
feedback at the level of the hypothalamus-pituitary as a
result of diminished testicular function.
Expected physiological relationships between basal LH
and testosterone, and between basal LH and E2 were not
found, but this may be due to the high variability of LH.
The few significant relationships between blood basal and
post GnRH levels of the same hormone indicate that the
basal level of a hormone do not reflect the response the
hormone to GnRH stimulation. Besser [1] also did not
find significant relationships between basal LH and FSH
and peak post GnRH values in a study of English men.
Peak LH and FSH levels after GnRH stimulation in this
study were respectively 10 and 2 times more than basal
levels, and consistent with those found in normal US and
English males [1,2]. In the study of English men, testoster-
one and E2 were found to have a slow response to GnRH
stimulation and did not change significantly over a 2 hour
period [1], which explaines the weak response of testoster-
one, E2 and inhibin to GnRh stimulation found in this
study.
Although most semen samples were collected via coitus
interruptus (there were only four semen samples pro-
duced via masturbation), semen parameters measured in
the study sample did not differ substantially from those
measured in similar populations via masturbation [13].
An expected positive relationship between basal SHBG
and age [27] was found. Age was not found to be a signif-
icant negative predictor of basal testosterone as expected
[27,28], but this might have been due to the relatively
high median age of the participants.
Table 3: Logistic regression model investigating the relationship 
between abnormal semen count and abnormally low basal 
inhibin
Variable (unit) Odds ratio (CI)*
Abnormally low semen count (< 20 × 106)
Abnormally low basal inhibin (< 100 pg/ml) 8.2 (1.4–49.2)
Age (years) 1.0 (0.92–1.1)
Abstinence (days) 1.0 (0.99–1.0)
Fever in the last 2 months 0.45 (0.07–3.1)
Physical abnormality 0.77 (0.1–6.3)
R2 = 0.18, n = 34
* CI : 95% Confidence interval
Table 4: Logistic regression model investigating the relationship 
between abnormal morphology count and abnormally high basal 
estradiol
Variable (unit) Odds ratio (CI)*
Abnormally low semen morphology (score < 2)
Abnormally high basal estradiol (< 100 pg/ml) 37.2 (2.1–655.2)
Age (years) 1.1 (0.96–1.4)
Abstinence (days) 0.98 (0.96–1.0)
Fever in the last 2 months 14.8 (0.8–273.2)
Physical abnormality 0.4 (0.02–8.5)
R2 = 0.4, n = 32
• CI : 95% Confidence intervalJournal of Occupational Medicine and Toxicology 2006, 1:21 http://www.occup-med.com/content/1/1/21
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Conclusion
The study has demonstrated the utility of serum basal
inhibin, FSH and estradiol for predicting impaired male
reproductive function. Abnormally low basal inhibin (<
100 pg/ml) was shown to be a marker of abnormally low
semen count (< 40 million) and had a positive relation-
ship with semen density. Abnormally high basal E2 (> 50
pg/ml) was shown to be a marker of abnormally low mor-
phology (< 2%) and motility (< 50%). Baseline FSH had
a negative relationship with semen count and density.
The GnRH challenge test appeared to add little value to
information provided by baseline levels of reproductive
hormones alone with regard to semen quality.
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